Seeing that the Trump administration’s drug dealers gave the “green light”-measures to import low-priced prescription drugs from Canada to reduce domestic drug prices will come into effect, Canada has urgently lit a “red light” to stop.
According to the British Broadcasting Corporation (BBC) on the 29th, Health Canada issued a statement announcing that it will implement a number of new measures, including a ban on the export of certain prescription drugs, to prevent drug shortages in the country. The Canadian Ministry of Health has also made it clear that the relevant measures are in response to the US’s desire to import large quantities of prescription drugs.
BBC: Canada bans large export of prescription drugs
On the 28th local time, Health Canada issued a statement stating, “The shortage of drugs is still a global challenge. The new crown epidemic has increased the demand for certain drugs and increased the complexity of ensuring the supply of needed drugs.
The Canadian government is still working hard. Ensure that Canadians can get the medicines they need when they need it.”
To this end, the statement said: “From November 27, certain drugs originally placed on the Canadian market will be prohibited from being sold outside of Canada, so as not to cause or aggravate drug shortages.”
While announcing this measure, the statement also “named” the United States and clearly stated that the above-mentioned decision is a response to a U.S. regulation that will come into effect.
“The measures announced today are based on consultations with the healthcare community that began in 2019 to respond to the U.S.
import prescription drug regulations that will take effect on November 30, 2020. The regulations are for U.S. licensed pharmacists or wholesalers The import of certain prescription drugs from the Canadian market has opened up a way.”
The statement said that Canada has repeatedly stated that relevant US regulations are not an effective way to reduce the price of domestic drugs in the United States, because the Canadian market is small and only accounts for global drug sales. 2%.
According to the BBC, due to the high cost of new drugs, the prices of some old generic drugs have also risen, and American drugmakers are facing strong criticism from many fields.
In July of this year, US President Trump signed an executive order allowing the United States to legally import low-cost drugs from Canada.
A month later, Canadian Prime Minister Trudeau said that he was very happy to provide materials and assistance to other countries where possible, but his first task was to ensure the needs of Canadians.